GLO Science

Revolutionary Technologies for Better Oral Care


Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9

GLO Science is an oral care technology innovator dedicated changing the way consumers and dental professionals alike think about the health and beauty of their smiles. Our revolutionary, proprietary G.L.O. technology gets teeth up to 5 times whiter in as few as 5 days – all without the mess and discomfort common with other whitening solutions on the market today.

With more than 500 practices across the United States already offering GLO Science products to their patients and $3.1 million in revenue in 2015 alone, GLO has made our name in the whitening market. Now we’re ready to expand our vision and apply the same innovative approach to therapeutic applications, and launch a new era of healthy, happy smiles across the United States and internationally.

Everyone wants a whiter, healthier smile – it's why teeth whitening is a $3 billion industry in the US alone.

But technology in the whitening industry leaves a lot to be desired: standard professional whitening methods are based on technologies that haven’t seen a meaningful upgrade in decades, while the most recent innovation in the home whitening space was the introduction of the Crest Whitestrip – over a decade ago.

In other words: people want whiter teeth, but look at the price they are paying to get them: suffering through long, expensive, uncomfortable ordeals – all for results that are middling at best, and actually can damage teeth and the surrounding tissue. And can whitening is just the tip of the iceberg – we'll get to the problems with current therapeutic treatment options in a bit. 

At GLO Science, we believe that dentists and their patients alike deserve better when it comes to their smile care options.

The GLO Science mission is simple: make smile care an essential part of any daily health routine by creating products that make smile management easy, effective and pain-free.

At the heart of GLO’s innovation is our patented Guided Light Optic (or G.L.O.) technology, which uses a combination of measured heat and light to zap the stains off teeth. The measured heat and light are delivered in what’s called a “closed system” mouthpiece which keeps the whitening oxygens from escaping the tooth surface. G.L.O. is paired with our innovative whitening gel G-Vials, which contain a minty fresh, stay-put formula that adheres to teeth while protecting gums and other sensitive soft tissues in the mouth from exposure.

The result: a faster, more efficient, more effective whitening process -- without the sensitivity and discomfort so common with other methods.

GLO Science takes a truly comprehensive approach to smile care offering products for both professional dentist office and at home use.

Distributed solely through licensed dentists, GLO Science’s Professional Line delivers high-impact whitening with dramatic results in just 32 minutes. Clinical studies of our technology found that patients achieve an average of 5 tooth shades, and 0% of patients that used GLO experienced painful "zingers" commonly associated with other professional teeth whitening procedures.

The GLO Brilliant Personal Teeth Whitening device features the same G.L.O. technology as in the professional line, delivered at a lower doses to give you the same professional teeth whitening results from the comfort and convenience of your own home.

The GLO Brilliant Personal Teeth Whitening line isn’t GLO’s only product for home use: we offer a whole line of products geared toward making it easy and affordable to get and keep the brilliant pearly whites you’re after. Our other products include:

As we’ve already mentioned, teeth whitening is just the beginning when it comes GLO Science’s vision for better, more effective smile care options. Now we’re setting our sights on our next challenge: therapeutic applications  to treat gum health - entering a market segment of about $6 billion, representing massive growth opportunities.

Current standard treatment methods for gum diseases suffer from many of the same problems as whitening technologies: they’re expensive, they’re uncomfortable, and by and large, they’re ineffective, too. Of the people that suffer from periodontal (gum) disease, only 40% are effectively treated using standard treatment methods.

At GLO, we started to wonder: would it be possible to take the same approach that helped us revolutionize teeth whitening and put it to work to reimagine therapeutic treatment as well?

The short answer: yes.

4 years after we first introduced our GLO technology for teeth whitening - following years of research development work we’re excited to announce our solution for therapeutic treatment. GLO’s therapeutic solution is scheduled for launch as of summer 2016, just awaiting final clinical test results. We already have seen great results: our first round of clinical testing showed superior results to the current leading treatment. Arestin, currently a business of about $120M, only in the US.

Our goal is to finalize clinical testing for our therapeutic solution in 2016. From there, we’ll start the process of introducing the technology to dental practices across the country, further solidifying our position as the leader in innovative technologies for the oral care industry.

Our dental professional customers agree: GLO Science is a game-changer in the world of smile care.

We’ve made tremendous progress since introducing GLO to the market in 2011. 2015 was our biggest and best year yet, and with further expansion in the professional dentistry market and the introduction of our new therapeutic product on the horizon, it only gets bigger and better from here.

Here are a few of the highlights of what we’ve achieved so far:

More than 500 dental practices are already offering GLO Science products to their patients. With sales efforts set to ramp up in  2016 by more than tripling the size of the direct sales force that number is on track to hit the thousands over the coming months. Beyond the professional dental channel GLO is a multi-channel proposition with a strong business also in e-commerce and prestige beauty retail.

Through various channels like our e-commerce website, partner dentist practices, and 15 key retail partners, we’ve sold more than 175,000 units of our GLO whitening device. Revenue for the 2015 fiscal year alone topped $3 million.

GLO Science's technology is protected by 10 patents, with an additional 16 patents pending.

Leading players from the personal care and the dental professional industries are already recognizing GLO’s revolutionary potential. We have established partnerships with Sephora, QVC and also Benco, a leading nationwide distributor in the dental professional channel. Furthermore, we just entered into a Global joint technology development partnership with one of the globally leading consumer products companies. All of which we believe is setting us up for accelerated growth in the very near future.

GLO Science has won 3 Thomas Edison Awards for innovation in the personal care space: in 2012, we won Silver for our GLO Brilliant Personal Teeth Whitening Device, and in 2013 we won two Gold awards for our Everyday GLO Teeth Whitening Maintenance Pen and GLO Solo products.

Up next for Glo: finalizing clinical trials on our new therapeutic product and getting GLO whitening and therapeutic solutions into more dental practices across the United States, while also strongly expanding our e-commerce business. Furthermore, we are preparing for the international expansion of GLO targeted no later than 2017 – with initial focus on Latin America (Brazil) and Europe (UK, Germany).

For more information about the future of GLO Science and how you can help make it happen, request access to the Business Plan tab of this profile and let’s talk!

Dr. Levine is an oral care industry visionary, inventor, clinical researcher, published author and thought leader. Holding 10 patents and 19 patents pending in oral care, Dr. Levine is responsible for modernizing the way people whiten their teeth. By combining his numerous patents with innovative dental technologies and a tenacious drive to always "make it safer, faster and more effective," Dr. Levine continues to up the ante with breakthrough professional techniques, and sleek, sophisticated at-home consumer and professional teeth whitening treatments.

Having spent over 15 years in the beauty retail industry, Stacey Levine brings comprehensive experience,unrivaled dedication and a unique vision to the GLO Science team as Co-Founder and Chief Marketing Officer. Stacey holds a Bachelor of Science from Boston University School of Management. Stacey sits on the board of Foundation Rwanda and co-founded the GLO Good Foundation, alongside Dr.Levine, which aims to provide oral health care to underserved populations across the globe.

Thomas's experience spans across CEO, General Manager and C-level Executive roles in consumer products, retail and services in North & South America, Europe / EMEA, Asia across multiple segments, including health & beauty care, food & beverage, pharmaceuticals and education. Thomas's resumé includes over over 20 years of executive leadership experience in the health & beauty care industry, with over 14 years with The Procter & Gamble Company in Europe, the US and Latin America, last as the Managing Director for the Personal Beauty Care Division in Latin America / Brazil. After leaving Procter & Gamble, Thomas spent 3 years as Managing Director / EVP of the international health & beauty retail and consumer products business at The Alliance Boots Company (Walgreens Boots). Thomas has broad experiences in developing new businesses and strategic partnerships in global licensing, third party distribution and multi-channel expansion.

Rick brings over 20 years of experience in finance, accounting and operations management to the GLO Science team. Rick started his career as a CPA for Price Waterhouse before spending 10 years with Hallmark Cards, Inc. in various financial and operational roles. He then transitioned to supporting several venture and private equitybacked companies the last 7 years as CFO and COO. His fatheris a dentist and he grew up in the dental office. He also was the CFO of the Natural Dentist, Inc. which he guided through an exit.

Betsy’s experience spans across over 15 years of executive leadership experience in expert and prestige beauty care with the L’Oreal company, last as the VP Marketing for L’Oreal Paris Skincare North America. Betsy built an excellent track record in leading brand businesses like Vichy and La Roche-Posay across the professional / expert and the consumer channels,having commercial leadership across marketing and sales as well as developing potent strategies with excellent go-to-market executions.

John Vitale is a distinguished dental industry veteran with well over 18 years experience in various leadership roles. His professional journey is one marketed with achievement and fast advancement across various organizations.  Starting his career as an engineer with Procter and Gamble, John turned towards a career in sales and sales leadership in the dental industry with Nobel Biocare and Keystone Dental, driving exceptional growth and organizational development.  John excelled in his leadership experience especially in these disruptive dental technology start-ups that he took to respective segment leadership. As such he is instrumental in taking Glo’s own sales capabilities and distributor partnerships to new heights, allowing Glo to claim a leadership position in the dental industry. 

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.

Request Access


No updates yet.


No backers yet.

Quick Signup TBD

You must have an account to do this!

the platform

Copyright © 2019 All rights reserved.

Fundable is a software as a service funding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.